BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35124196)

  • 21. A large-scale binding and functional map of human RNA-binding proteins.
    Van Nostrand EL; Freese P; Pratt GA; Wang X; Wei X; Xiao R; Blue SM; Chen JY; Cody NAL; Dominguez D; Olson S; Sundararaman B; Zhan L; Bazile C; Bouvrette LPB; Bergalet J; Duff MO; Garcia KE; Gelboin-Burkhart C; Hochman M; Lambert NJ; Li H; McGurk MP; Nguyen TB; Palden T; Rabano I; Sathe S; Stanton R; Su A; Wang R; Yee BA; Zhou B; Louie AL; Aigner S; Fu XD; Lécuyer E; Burge CB; Graveley BR; Yeo GW
    Nature; 2020 Jul; 583(7818):711-719. PubMed ID: 32728246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RBPTD: a database of cancer-related RNA-binding proteins in humans.
    Li K; Guo ZW; Zhai XM; Yang XX; Wu YS; Liu TC
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32047888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.
    Jonas K; Calin GA; Pichler M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
    Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
    RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer.
    Mehta M; Raguraman R; Ramesh R; Munshi A
    Adv Drug Deliv Rev; 2022 Dec; 191():114569. PubMed ID: 36252617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy.
    Mir C; Garcia-Mayea Y; LLeonart ME
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):69-83. PubMed ID: 35772609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.
    Lang B; Yang JS; Garriga-Canut M; Speroni S; Aschern M; Gili M; Hoffmann T; Tartaglia GG; Maurer SP
    Nucleic Acids Res; 2021 Jul; 49(12):6702-6721. PubMed ID: 34133714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.
    Alemi F; Poornajaf Y; Hosseini F; Vahedian V; Gharekhani M; Shoorei H; Taheri M
    Mol Biol Rep; 2024 Feb; 51(1):308. PubMed ID: 38366290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA.
    Wen D; Huang Z; Li Z; Tang X; Wen X; Liu J; Li M
    J Cell Physiol; 2020 Oct; 235(10):7592-7603. PubMed ID: 32324262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA-binding proteins and long noncoding RNAs in intestinal epithelial autophagy and barrier function.
    Xiao L; Rao JN; Wang JY
    Tissue Barriers; 2021 Apr; 9(2):1895648. PubMed ID: 33709880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
    Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
    BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristic landscape of lncRNAs classified by RBP-lncRNA interactions across 10 cancers.
    Zhang Q; Wei Y; Yan Z; Wu C; Chang Z; Zhu Y; Li K; Xu Y
    Mol Biosyst; 2017 Jun; 13(6):1142-1151. PubMed ID: 28443890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT).
    Bebee TW; Cieply BW; Carstens RP
    Adv Exp Med Biol; 2014; 825():267-302. PubMed ID: 25201109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs.
    Janakiraman H; House RP; Gangaraju VK; Diehl JA; Howe PH; Palanisamy V
    Mol Cancer Res; 2018 Apr; 16(4):567-579. PubMed ID: 29555893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-binding proteins in human genetic disease.
    Lukong KE; Chang KW; Khandjian EW; Richard S
    Trends Genet; 2008 Aug; 24(8):416-25. PubMed ID: 18597886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
    Han L; Huang C; Zhang S
    Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
    Wang G; Cui Y; Zhang G; Garen A; Song X
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16794-8. PubMed ID: 19805375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.